Alzheimer’s progression tracked prior to dementia
A long-term study of older adults led by Anne Fagan (right) has helped validate a new system for identifying and classifying older adults with preclinical Alzheimer’s disease. Many researchers think this stage of the disease, which can last a decade or more, is critical window for slowing or stopping Alzheimer’s treatments.
Brain network decay detected in early Alzheimer’s
In patients with early Alzheimer’s disease, disruptions
in brain networks emerge about the same time as chemical markers of the
disease appear in the spinal fluid, School of Medicine researchers have shown. Pictured is senior author of the study, Beau Ances, MD, PhD, associate professor of neurology and of biomedical engineering.